{"transactions":[{"id":720865,"issuer":{"id":1933,"kind":"organization","name":"Autolus Therapeutics plc","symbol":"AUTL"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true}}],"security":"Share Option (Right to Buy)","published_at":"2026-07-01T20:04:49.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":47500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Share options vest in twelve equal monthly installments commencing on July 29, 2026."}],"balance_after":47500,"derivative":{"exercise_price":1.61,"expiration_date":"2036-06-29","underlying":"American Depositary Shares","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0001730463-26-000091","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219016/000173046326000091/form4.xml","form_type":"4"}},{"id":720864,"issuer":{"id":1933,"kind":"organization","name":"Autolus Therapeutics plc","symbol":"AUTL"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true}}],"security":"Restricted Share Units","published_at":"2026-07-01T20:04:49.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":31667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in one installment on June 29, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in one installment on June 29, 2027."}],"balance_after":31667,"derivative":{"underlying":"American Depositary Shares","underlying_shares":31667},"source":{"system":"sec-edgar","filing":"0001730463-26-000091","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219016/000173046326000091/form4.xml","form_type":"4"}},{"id":723868,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-29T20:30:32.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock conditionally approved by the Board of Directors on May 15, 2026, subject to approval of an amendment to the Company's 2019 Omnibus Equity Incentive Plan, as amended, by the Company's stockholders, which approval was obtained at the Company's 2026 Annual Meeting of Stockholders held on June 29, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in thirty-six (36) equal installments on each monthly anniversary of May 15, 2026."}],"balance_after":100000,"derivative":{"exercise_price":12.08,"expiration_date":"2036-05-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193805-26-000883","document":"e665603_4-bonney.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380526000883/e665603_4-bonney.xml","form_type":"4"}},{"id":1062550,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-08-19T21:26:02.000Z","date":"2025-08-18","kind":"exercise","planned":true,"acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option was fully vested as of June 3, 2017."}],"balance_after":0,"derivative":{"exercise_price":70.2,"exercise_date":"2017-06-03","expiration_date":"2026-06-03","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001735276-25-000087","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000087/edgardoc.xml","form_type":"4"}},{"id":1062549,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T21:26:02.000Z","date":"2025-08-18","kind":"sale","planned":true,"acquired":false,"shares":11250,"price":450,"value":5062500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024."}],"balance_after":16804,"source":{"system":"sec-edgar","filing":"0001735276-25-000087","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000087/edgardoc.xml","form_type":"4"}},{"id":1062548,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T21:26:02.000Z","date":"2025-08-18","kind":"exercise","planned":true,"acquired":true,"shares":11250,"price":70.2,"value":789750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024."}],"balance_after":28054,"source":{"system":"sec-edgar","filing":"0001735276-25-000087","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000087/edgardoc.xml","form_type":"4"}},{"id":1143327,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-05-19T20:17:09.000Z","date":"2025-05-15","kind":"exercise","planned":true,"acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"The stock option was fully vested as of June 1, 2016."}],"balance_after":0,"derivative":{"exercise_price":131.21,"exercise_date":"2016-06-01","expiration_date":"2025-06-01","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001735276-25-000072","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000072/edgardoc.xml","form_type":"4"}},{"id":1143326,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:17:09.000Z","date":"2025-05-15","kind":"sale","planned":true,"acquired":false,"shares":1617,"price":283.83,"value":458953.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $283.54 to $284.22. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":16804,"source":{"system":"sec-edgar","filing":"0001735276-25-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000072/edgardoc.xml","form_type":"4"}},{"id":1143325,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:17:09.000Z","date":"2025-05-15","kind":"sale","planned":true,"acquired":false,"shares":1728,"price":282.81,"value":488695.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $282.40 to $283.37. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":18421,"source":{"system":"sec-edgar","filing":"0001735276-25-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000072/edgardoc.xml","form_type":"4"}},{"id":1143324,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:17:09.000Z","date":"2025-05-15","kind":"sale","planned":true,"acquired":false,"shares":802,"price":282.03,"value":226188.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $281.39 to $282.26. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":20149,"source":{"system":"sec-edgar","filing":"0001735276-25-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000072/edgardoc.xml","form_type":"4"}},{"id":1143323,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:17:09.000Z","date":"2025-05-15","kind":"sale","planned":true,"acquired":false,"shares":372,"price":281.1,"value":104569.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $280.38 to $281.37. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":20951,"source":{"system":"sec-edgar","filing":"0001735276-25-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000072/edgardoc.xml","form_type":"4"}},{"id":1143322,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:17:09.000Z","date":"2025-05-15","kind":"sale","planned":true,"acquired":false,"shares":432,"price":280.03,"value":120972.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $279.26 to $280.17. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":21323,"source":{"system":"sec-edgar","filing":"0001735276-25-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000072/edgardoc.xml","form_type":"4"}},{"id":1143321,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:17:09.000Z","date":"2025-05-15","kind":"sale","planned":true,"acquired":false,"shares":1239,"price":278.01,"value":344454.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $277.77 to $278.43. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":21755,"source":{"system":"sec-edgar","filing":"0001735276-25-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000072/edgardoc.xml","form_type":"4"}},{"id":1143320,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:17:09.000Z","date":"2025-05-15","kind":"sale","planned":true,"acquired":false,"shares":1263,"price":277.16,"value":350053.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $276.55 to $277.45. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":22994,"source":{"system":"sec-edgar","filing":"0001735276-25-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000072/edgardoc.xml","form_type":"4"}},{"id":1143319,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:17:09.000Z","date":"2025-05-15","kind":"sale","planned":true,"acquired":false,"shares":301,"price":275.63,"value":82964.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $275.11 to $276.05. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":24257,"source":{"system":"sec-edgar","filing":"0001735276-25-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000072/edgardoc.xml","form_type":"4"}},{"id":1143318,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:17:09.000Z","date":"2025-05-15","kind":"sale","planned":true,"acquired":false,"shares":882,"price":273.75,"value":241447.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $273.61 to $274.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":24558,"source":{"system":"sec-edgar","filing":"0001735276-25-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000072/edgardoc.xml","form_type":"4"}},{"id":1143317,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:17:09.000Z","date":"2025-05-15","kind":"sale","planned":true,"acquired":false,"shares":660,"price":273.16,"value":180285.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $272.60 to $273.59. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":25440,"source":{"system":"sec-edgar","filing":"0001735276-25-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000072/edgardoc.xml","form_type":"4"}},{"id":1143316,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:17:09.000Z","date":"2025-05-15","kind":"sale","planned":true,"acquired":false,"shares":431,"price":271.68,"value":117094.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $271.44 to $272.10. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":26100,"source":{"system":"sec-edgar","filing":"0001735276-25-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000072/edgardoc.xml","form_type":"4"}},{"id":1143315,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:17:09.000Z","date":"2025-05-15","kind":"sale","planned":true,"acquired":false,"shares":245,"price":269.79,"value":66098.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $269.53 to $269.88. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":26531,"source":{"system":"sec-edgar","filing":"0001735276-25-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000072/edgardoc.xml","form_type":"4"}},{"id":1143314,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:17:09.000Z","date":"2025-05-15","kind":"sale","planned":true,"acquired":false,"shares":729,"price":268.56,"value":195780.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $268.28 to $269.16. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":26776,"source":{"system":"sec-edgar","filing":"0001735276-25-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000072/edgardoc.xml","form_type":"4"}},{"id":1143313,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:17:09.000Z","date":"2025-05-15","kind":"sale","planned":true,"acquired":false,"shares":549,"price":267.14,"value":146659.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $266.87 to $267.72. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":27505,"source":{"system":"sec-edgar","filing":"0001735276-25-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000072/edgardoc.xml","form_type":"4"}},{"id":1143312,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:17:09.000Z","date":"2025-05-15","kind":"exercise","planned":true,"acquired":true,"shares":11250,"price":131.21,"value":1476112.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on November 12, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."}],"balance_after":28054,"source":{"system":"sec-edgar","filing":"0001735276-25-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000072/edgardoc.xml","form_type":"4"}},{"id":1152518,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-05-12T20:07:11.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":1558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":1558,"derivative":{"exercise_price":258.35,"exercise_date":"2026-05-08","expiration_date":"2035-05-08","underlying":"Common Stock","underlying_shares":1558},"source":{"system":"sec-edgar","filing":"0001735276-25-000067","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000067/edgardoc.xml","form_type":"4"}},{"id":1152517,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-12T20:07:11.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":16804,"source":{"system":"sec-edgar","filing":"0001735276-25-000067","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000067/edgardoc.xml","form_type":"4"}},{"id":1509301,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2024-05-20T20:05:01.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":5228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":5228,"derivative":{"exercise_price":151.22,"exercise_date":"2025-05-16","expiration_date":"2034-05-16","underlying":"Common Stock","underlying_shares":5228},"source":{"system":"sec-edgar","filing":"0001735276-24-000048","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000048/edgardoc.xml","form_type":"4"}},{"id":1698107,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2023-12-29T21:03:28.000Z","date":"2023-12-27","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option was fully vested as of 12/17/2017."}],"balance_after":0,"derivative":{"exercise_price":96.45,"expiration_date":"2024-12-17","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001735276-23-000081","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000081/edgardoc.xml","form_type":"4"}},{"id":1698106,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-29T21:03:28.000Z","date":"2023-12-27","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":195,"value":5850000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2023."}],"balance_after":16029,"source":{"system":"sec-edgar","filing":"0001735276-23-000081","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000081/edgardoc.xml","form_type":"4"}},{"id":1698105,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-29T21:03:28.000Z","date":"2023-12-27","kind":"exercise","planned":true,"acquired":true,"shares":30000,"price":96.45,"value":2893500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2023."}],"balance_after":46029,"source":{"system":"sec-edgar","filing":"0001735276-23-000081","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000081/edgardoc.xml","form_type":"4"}},{"id":1815187,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-08-04T20:02:49.000Z","date":"2023-08-02","kind":"exercise","planned":false,"acquired":false,"shares":22477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"Each restricted stock unit represents a contingent right to receive one share of ALNY common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The restricted stock units vest in full on the second anniversary of the grant date, August 2, 2021, provided the Reporting Person continues to serve as a director through such anniversary date, or earlier than such anniversary date if he ceases to serve as a director other than for cause or by his voluntary resignation as Executive Chair without the consent of the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"The restricted stock units vest in full on the second anniversary of the grant date, August 2, 2021, provided the Reporting Person continues to serve as a director through such anniversary date, or earlier than such anniversary date if he ceases to serve as a director other than for cause or by his voluntary resignation as Executive Chair without the consent of the Board of Directors."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":22477},"source":{"system":"sec-edgar","filing":"0001735276-23-000071","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000071/edgardoc.xml","form_type":"4"}},{"id":1815186,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-04T20:02:49.000Z","date":"2023-08-03","kind":"sale","planned":false,"acquired":false,"shares":450,"price":187.71,"value":84469.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $187.58 to $187.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":16029,"source":{"system":"sec-edgar","filing":"0001735276-23-000071","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000071/edgardoc.xml","form_type":"4"}},{"id":1815185,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-04T20:02:49.000Z","date":"2023-08-03","kind":"sale","planned":false,"acquired":false,"shares":1389,"price":187.04,"value":259798.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $186.53 to $187.53. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":16479,"source":{"system":"sec-edgar","filing":"0001735276-23-000071","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000071/edgardoc.xml","form_type":"4"}},{"id":1815184,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-04T20:02:49.000Z","date":"2023-08-03","kind":"sale","planned":false,"acquired":false,"shares":1714,"price":185.99,"value":318786.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $185.49 to $186.31. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":17868,"source":{"system":"sec-edgar","filing":"0001735276-23-000071","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000071/edgardoc.xml","form_type":"4"}},{"id":1815183,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-04T20:02:49.000Z","date":"2023-08-03","kind":"sale","planned":false,"acquired":false,"shares":1535,"price":184.89,"value":283806.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $184.48 to $185.44. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":19582,"source":{"system":"sec-edgar","filing":"0001735276-23-000071","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000071/edgardoc.xml","form_type":"4"}},{"id":1815182,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-04T20:02:49.000Z","date":"2023-08-03","kind":"sale","planned":false,"acquired":false,"shares":560,"price":183.75,"value":102900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $183.20 to $184.15. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":21117,"source":{"system":"sec-edgar","filing":"0001735276-23-000071","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000071/edgardoc.xml","form_type":"4"}},{"id":1815181,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-04T20:02:49.000Z","date":"2023-08-03","kind":"sale","planned":false,"acquired":false,"shares":500,"price":182.45,"value":91225.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $182.13 to $183.06. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":21677,"source":{"system":"sec-edgar","filing":"0001735276-23-000071","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000071/edgardoc.xml","form_type":"4"}},{"id":1815180,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-04T20:02:49.000Z","date":"2023-08-03","kind":"sale","planned":false,"acquired":false,"shares":300,"price":181.08,"value":54324.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $181.00 to $181.25. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":22177,"source":{"system":"sec-edgar","filing":"0001735276-23-000071","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000071/edgardoc.xml","form_type":"4"}},{"id":1815179,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-04T20:02:49.000Z","date":"2023-08-02","kind":"exercise","planned":false,"acquired":true,"shares":22477,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22477,"source":{"system":"sec-edgar","filing":"0001735276-23-000071","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000071/edgardoc.xml","form_type":"4"}},{"id":1885130,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2023-05-19T20:03:31.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":3454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":3454,"derivative":{"exercise_price":189.87,"exercise_date":"2024-05-18","expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":3454},"source":{"system":"sec-edgar","filing":"0001735276-23-000060","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000060/edgardoc.xml","form_type":"4"}},{"id":2618196,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair"}}],"security":"Restricted Stock Units","published_at":"2021-08-03T23:31:30.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":22477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ALNY common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full on the earlier of August 2, 2023 and the date the Reporting Person ceases to serve as a director of the Company other than for cause or by his voluntary resignation as Executive Chair without the consent of the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in full on the earlier of August 2, 2023 and the date the Reporting Person ceases to serve as a director of the Company other than for cause or by his voluntary resignation as Executive Chair without the consent of the Board of Directors."}],"balance_after":22477,"derivative":{"underlying":"Common Stock","underlying_shares":22477},"source":{"system":"sec-edgar","filing":"0001735276-21-000075","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527621000075/edgardoc.xml","form_type":"4"}},{"id":2630796,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2021-07-19T20:21:34.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":4032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":4032,"derivative":{"exercise_price":171.95,"exercise_date":"2022-07-15","expiration_date":"2031-07-14","underlying":"Common Stock","underlying_shares":4032},"source":{"system":"sec-edgar","filing":"0001735276-21-000069","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527621000069/edgardoc.xml","form_type":"4"}},{"id":373948,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2021-07-01T21:17:22.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":345.331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":9341.7,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":345.331},"source":{"system":"sec-edgar","filing":"0000014272-21-000175","document":"wf-form4_162517420355316.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427221000175/wf-form4_162517420355316.xml","form_type":"4"}},{"id":2647813,"issuer":{"id":129745,"kind":"organization","name":"Kaleido Biosciences, Inc.","symbol":"KLDO"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T16:25:22.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The original Form 4, filed on July 1, 2020, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the exercise price as $7.42 when in fact the exercise price is 7.43."}],"balance_after":15000,"derivative":{"exercise_price":7.43,"exercise_date":"2021-06-30","expiration_date":"2030-06-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-044396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751299/000120919121044396/doc4.xml","form_type":"4"}},{"id":2647812,"issuer":{"id":129745,"kind":"organization","name":"Kaleido Biosciences, Inc.","symbol":"KLDO"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T16:25:22.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15000,"derivative":{"exercise_price":7.44,"exercise_date":"2022-06-30","expiration_date":"2031-06-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-044396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751299/000120919121044396/doc4.xml","form_type":"4"}},{"id":374411,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-14T22:56:35.000Z","date":"2021-06-13","kind":"exercise","acquired":false,"shares":902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019."}],"balance_after":0,"derivative":{"expiration_date":"2021-06-13","underlying":"Common Stock, $0.10 par value","underlying_shares":902},"source":{"system":"sec-edgar","filing":"0000014272-21-000150","document":"wf-form4_162371137972613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427221000150/wf-form4_162371137972613.xml","form_type":"4"}},{"id":374410,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.10 par value","published_at":"2021-06-14T22:56:35.000Z","date":"2021-06-13","kind":"exercise","acquired":true,"shares":902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit converts into one share of common stock upon vesting."}],"balance_after":12501,"source":{"system":"sec-edgar","filing":"0000014272-21-000150","document":"wf-form4_162371137972613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427221000150/wf-form4_162371137972613.xml","form_type":"4"}},{"id":374688,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-04T20:37:20.000Z","date":"2021-06-03","kind":"exercise","acquired":false,"shares":2949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020."}],"balance_after":2949,"derivative":{"expiration_date":"2022-06-03","underlying":"Common Stock, $0.10 par value","underlying_shares":2949},"source":{"system":"sec-edgar","filing":"0000014272-21-000146","document":"wf-form4_162283897591681.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427221000146/wf-form4_162283897591681.xml","form_type":"4"}},{"id":374687,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.10 par value","published_at":"2021-06-04T20:37:20.000Z","date":"2021-06-03","kind":"exercise","acquired":true,"shares":2949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit converts into one share of common stock upon vesting."}],"balance_after":11599,"source":{"system":"sec-edgar","filing":"0000014272-21-000146","document":"wf-form4_162283897591681.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427221000146/wf-form4_162283897591681.xml","form_type":"4"}},{"id":2683363,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-03T22:33:05.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":18188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (a) June 1, 2022 or (b) the next annual meeting of the Issuer's stockholders."}],"balance_after":18188,"derivative":{"exercise_price":12.91,"expiration_date":"2031-05-31","underlying":"Common Stock","underlying_shares":18188},"source":{"system":"sec-edgar","filing":"0000899243-21-021843","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924321021843/doc4.xml","form_type":"4"}},{"id":377266,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2021-04-02T17:20:42.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":365.516,"price":63.13,"value":23075.02508,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":8930.258,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":365.516},"source":{"system":"sec-edgar","filing":"0000014272-21-000120","document":"wf-form4_161738398243865.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427221000120/wf-form4_161738398243865.xml","form_type":"4"}},{"id":381066,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2021-02-04T00:15:25.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":3054.171,"price":62.21,"value":189999.97791,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":8564.742,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":3054.171},"source":{"system":"sec-edgar","filing":"0000014272-21-000044","document":"wf-form4_161239771027164.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427221000044/wf-form4_161239771027164.xml","form_type":"4"}},{"id":382340,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2021-01-06T01:10:25.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":371.997,"price":62.03,"value":23074.97391,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":5467.507,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":371.997},"source":{"system":"sec-edgar","filing":"0000014272-21-000018","document":"wf-form4_160989540756255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427221000018/wf-form4_160989540756255.xml","form_type":"4"}},{"id":385270,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2020-10-02T20:29:39.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":382.733,"price":60.29,"value":23074.97257,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":5057.255,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":382.733},"source":{"system":"sec-edgar","filing":"0000014272-20-000261","document":"wf-form4_160167056399310.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427220000261/wf-form4_160167056399310.xml","form_type":"4"}},{"id":3089169,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2020-07-06T20:52:45.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":4581,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4581,"derivative":{"exercise_price":148.77,"exercise_date":"2021-07-01","expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":4581},"source":{"system":"sec-edgar","filing":"0001735276-20-000081","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527620000081/edgardoc.xml","form_type":"4"}},{"id":388746,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2020-07-02T20:58:48.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":392.432,"price":58.8,"value":23075.0016,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":4639.199,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":392.432},"source":{"system":"sec-edgar","filing":"0000014272-20-000213","document":"wf-form4_159372347744271.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427220000213/wf-form4_159372347744271.xml","form_type":"4"}},{"id":3095407,"issuer":{"id":129745,"kind":"organization","name":"Kaleido Biosciences, Inc.","symbol":"KLDO"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-01T16:15:26.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15000,"derivative":{"exercise_price":7.42,"exercise_date":"2021-06-30","expiration_date":"2030-06-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-039723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751299/000120919120039723/doc4.xml","form_type":"4"}},{"id":389231,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-16T21:16:10.000Z","date":"2020-06-14","kind":"exercise","acquired":false,"shares":558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F3","text":"On June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018."}],"balance_after":0,"derivative":{"expiration_date":"2020-06-14","underlying":"Common Stock, $0.10 par value","underlying_shares":558},"source":{"system":"sec-edgar","filing":"0000014272-20-000195","document":"wf-form4_159234215241704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427220000195/wf-form4_159234215241704.xml","form_type":"4"}},{"id":389230,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-16T21:16:10.000Z","date":"2020-06-13","kind":"exercise","acquired":false,"shares":903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019."}],"balance_after":902,"derivative":{"expiration_date":"2021-06-13","underlying":"Common Stock, $0.10 par value","underlying_shares":903},"source":{"system":"sec-edgar","filing":"0000014272-20-000195","document":"wf-form4_159234215241704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427220000195/wf-form4_159234215241704.xml","form_type":"4"}},{"id":389229,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.10 par value","published_at":"2020-06-16T21:16:10.000Z","date":"2020-06-14","kind":"exercise","acquired":true,"shares":558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit converts into one share of common stock upon vesting."}],"balance_after":8650,"source":{"system":"sec-edgar","filing":"0000014272-20-000195","document":"wf-form4_159234215241704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427220000195/wf-form4_159234215241704.xml","form_type":"4"}},{"id":389228,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.10 par value","published_at":"2020-06-16T21:16:10.000Z","date":"2020-06-13","kind":"exercise","acquired":true,"shares":903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit converts into one share of common stock upon vesting."}],"balance_after":8092,"source":{"system":"sec-edgar","filing":"0000014272-20-000195","document":"wf-form4_159234215241704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427220000195/wf-form4_159234215241704.xml","form_type":"4"}},{"id":389595,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.10 par value","published_at":"2020-06-09T23:16:24.000Z","date":"2019-12-04","kind":"purchase","acquired":true,"shares":88,"price":58.9,"value":5183.2,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Due to an administrative error, this Form 4 was not timely filed."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the current total of securities beneficially owned by the reporting person, including the reported transaction."}],"balance_after":7189,"source":{"system":"sec-edgar","filing":"0000014272-20-000183","document":"wf-form4_159174456763815.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427220000183/wf-form4_159174456763815.xml","form_type":"4"}},{"id":3116453,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-09T20:26:11.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":18188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (a) June 5, 2021 or (b) the next annual meeting of the Issuer's stockholders."}],"balance_after":18188,"derivative":{"exercise_price":9.99,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":18188},"source":{"system":"sec-edgar","filing":"0000899243-20-015799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924320015799/doc4.xml","form_type":"4"}},{"id":389720,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-05T20:40:23.000Z","date":"2020-06-03","kind":"exercise","acquired":false,"shares":2949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020."}],"balance_after":5898,"derivative":{"expiration_date":"2022-06-03","underlying":"Common Stock, $0.10 par value","underlying_shares":2949},"source":{"system":"sec-edgar","filing":"0000014272-20-000177","document":"wf-form4_159138960535420.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427220000177/wf-form4_159138960535420.xml","form_type":"4"}},{"id":389719,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.10 par value","published_at":"2020-06-05T20:40:23.000Z","date":"2020-06-03","kind":"exercise","acquired":true,"shares":2949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit converts into one share of common stock upon vesting."}],"balance_after":7189,"source":{"system":"sec-edgar","filing":"0000014272-20-000177","document":"wf-form4_159138960535420.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427220000177/wf-form4_159138960535420.xml","form_type":"4"}},{"id":392417,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2020-04-02T20:50:58.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":413.976,"price":55.74,"value":23075.02224,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":4215.29,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":413.976},"source":{"system":"sec-edgar","filing":"0000014272-20-000143","document":"wf-form4_158586064088540.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427220000143/wf-form4_158586064088540.xml","form_type":"4"}},{"id":3242237,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-02-29T01:06:31.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":3685,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3685,"derivative":{"exercise_price":114.47,"exercise_date":"2021-02-28","expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":3685},"source":{"system":"sec-edgar","filing":"0001209191-20-014237","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120014237/doc4.xml","form_type":"4"}},{"id":3242236,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-29T01:06:31.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":2075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on February 28, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on February 28, 2021."}],"balance_after":9126,"source":{"system":"sec-edgar","filing":"0001209191-20-014237","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120014237/doc4.xml","form_type":"4"}},{"id":3270784,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-14T21:55:10.000Z","date":"2019-02-27","kind":"gift","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":65346,"source":{"system":"sec-edgar","filing":"0000899243-20-004667","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924320004667/doc5.xml","form_type":"5"}},{"id":396234,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2020-02-04T23:04:55.000Z","date":"2020-02-01","kind":"grant","acquired":true,"shares":3018.268,"price":62.95,"value":189999.9706,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":3801.314,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":3018.268},"source":{"system":"sec-edgar","filing":"0000014272-20-000060","document":"wf-form4_158085747868474.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427220000060/wf-form4_158085747868474.xml","form_type":"4"}},{"id":397511,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2020-01-03T23:48:46.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":126.239,"price":64.19,"value":8103.28141,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":782.152,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":126.239},"source":{"system":"sec-edgar","filing":"0000014272-20-000016","document":"wf-form4_157809530940270.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427220000016/wf-form4_157809530940270.xml","form_type":"4"}},{"id":398552,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-11-27T22:34:47.000Z","date":"2019-11-20","kind":"grant","acquired":true,"shares":8847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The restricted stock unit vests in three equal annual installments beginning on June 3, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The restricted stock unit vests in three equal annual installments beginning on June 3, 2020."}],"balance_after":8847,"derivative":{"expiration_date":"2022-06-03","underlying":"Common Stock, $0.10 par value","underlying_shares":8847},"source":{"system":"sec-edgar","filing":"0000014272-19-000216","document":"wf-form4a_157489406834103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427219000216/wf-form4a_157489406834103.xml","form_type":"4/A","original_submission_date":"2019-11-22"}},{"id":398551,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-11-27T22:34:47.000Z","date":"2019-11-20","kind":"grant","acquired":true,"shares":1805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The restricted stock unit vests in three equal annual installments beginning on June 13, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock unit vests in three equal annual installments beginning on June 13, 2019."}],"balance_after":1805,"derivative":{"expiration_date":"2021-06-13","underlying":"Common Stock, $0.10 par value","underlying_shares":1805},"source":{"system":"sec-edgar","filing":"0000014272-19-000216","document":"wf-form4a_157489406834103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427219000216/wf-form4a_157489406834103.xml","form_type":"4/A","original_submission_date":"2019-11-22"}},{"id":398550,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-11-27T22:34:47.000Z","date":"2019-11-20","kind":"grant","acquired":true,"shares":558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The restricted stock unit vests in three equal annual installments beginning on June 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit converts into one share of common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock unit vests in three equal annual installments beginning on June 14, 2018."}],"balance_after":558,"derivative":{"expiration_date":"2020-06-14","underlying":"Common Stock, $0.10 par value","underlying_shares":558},"source":{"system":"sec-edgar","filing":"0000014272-19-000216","document":"wf-form4a_157489406834103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427219000216/wf-form4a_157489406834103.xml","form_type":"4/A","original_submission_date":"2019-11-22"}},{"id":398549,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2019-11-27T22:34:47.000Z","date":"2019-11-20","kind":"grant","acquired":true,"shares":24674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares are currently exercisable. Pursuant to the Merger, the stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":24674,"derivative":{"exercise_price":41.61,"expiration_date":"2028-06-13","underlying":"Common Stock, $0.10 par value","underlying_shares":24674},"source":{"system":"sec-edgar","filing":"0000014272-19-000216","document":"wf-form4a_157489406834103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427219000216/wf-form4a_157489406834103.xml","form_type":"4/A","original_submission_date":"2019-11-22"}},{"id":398548,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2019-11-27T22:34:47.000Z","date":"2019-11-20","kind":"grant","acquired":true,"shares":19635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares are currently exercisable. Pursuant to the Merger, the stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":19635,"derivative":{"exercise_price":64.73,"expiration_date":"2027-06-14","underlying":"Common Stock, $0.10 par value","underlying_shares":19635},"source":{"system":"sec-edgar","filing":"0000014272-19-000216","document":"wf-form4a_157489406834103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427219000216/wf-form4a_157489406834103.xml","form_type":"4/A","original_submission_date":"2019-11-22"}},{"id":398547,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2019-11-27T22:34:47.000Z","date":"2019-11-20","kind":"grant","acquired":true,"shares":20460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares are currently exercisable. Pursuant to the Merger, the stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":20460,"derivative":{"exercise_price":53.76,"expiration_date":"2026-06-15","underlying":"Common Stock, $0.10 par value","underlying_shares":20460},"source":{"system":"sec-edgar","filing":"0000014272-19-000216","document":"wf-form4a_157489406834103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427219000216/wf-form4a_157489406834103.xml","form_type":"4/A","original_submission_date":"2019-11-22"}},{"id":398546,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2019-11-27T22:34:47.000Z","date":"2019-11-20","kind":"grant","acquired":true,"shares":18700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares are currently exercisable. Pursuant to the Merger, the stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":18700,"derivative":{"exercise_price":59.98,"expiration_date":"2025-06-17","underlying":"Common Stock, $0.10 par value","underlying_shares":18700},"source":{"system":"sec-edgar","filing":"0000014272-19-000216","document":"wf-form4a_157489406834103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427219000216/wf-form4a_157489406834103.xml","form_type":"4/A","original_submission_date":"2019-11-22"}},{"id":398545,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2019-11-27T22:34:47.000Z","date":"2019-11-20","kind":"grant","acquired":true,"shares":18700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All of the shares are currently exercisable. Pursuant to the Merger, the stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":18700,"derivative":{"exercise_price":61.92,"expiration_date":"2025-04-14","underlying":"Common Stock, $0.10 par value","underlying_shares":18700},"source":{"system":"sec-edgar","filing":"0000014272-19-000216","document":"wf-form4a_157489406834103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427219000216/wf-form4a_157489406834103.xml","form_type":"4/A","original_submission_date":"2019-11-22"}},{"id":398544,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.10 par value","published_at":"2019-11-27T22:34:47.000Z","date":"2019-11-20","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Trust"},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0000014272-19-000216","document":"wf-form4a_157489406834103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427219000216/wf-form4a_157489406834103.xml","form_type":"4/A","original_submission_date":"2019-11-22"}},{"id":398543,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.10 par value","published_at":"2019-11-27T22:34:47.000Z","date":"2019-11-20","kind":"grant","acquired":true,"shares":4069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 20, 2019 (\"Closing Date\"), Bristol-Myers Squibb Company (\"BMS\") completed the previously announced acquisition of Celgene Corporation (\"Celgene\") contemplated pursuant to the terms and conditions of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 2, 2019, by and among BMS, Burgundy Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of BMS (\"Merger Sub\"), and Celgene.  Under the Merger Agreement, Merger Sub merged with and into Celgene with Celgene surviving as a direct wholly owned subsidiary of BMS (the \"Merger\"). Due to an administrative delay in calculations surrounding the total Merger Consideration (defined below) received by the Reporting Person, this Form 4 is being amended to report the correct number of securities beneficially owned by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to the Merger, each outstanding share of Celgene common stock, par value $0.01 per share, was converted into the right to receive (x) $50 in cash, without interest, (y) one share of BMS common stock, par value $0.10 per share and (z) one tradeable contingent value right ( \"CVR\") per share or, with respect to equity awards (in some cases), per share underlying each such equity award (\"Merger Consideration\"). Each CVR will represent the right to receive $9.00 in cash upon Federal Drug Administration (\"FDA\") approval of a specified set of milestones, as set forth in the Contingent Value Rights Agreement, dated as of November 20, 2019, between BMS and Equiniti Trust Company, as trustee."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes settlement of 1860 deferred share units that were paid out in connection with the Merger."}],"balance_after":4069,"source":{"system":"sec-edgar","filing":"0000014272-19-000216","document":"wf-form4a_157489406834103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427219000216/wf-form4a_157489406834103.xml","form_type":"4/A","original_submission_date":"2019-11-22"}},{"id":398762,"issuer":{"id":1662,"kind":"organization","name":"BRISTOL MYERS SQUIBB CO","symbol":"BMY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Units","published_at":"2019-11-22T21:59:32.000Z","date":"2019-11-20","kind":"grant","acquired":true,"shares":655.913,"price":56.41,"value":37000.05233,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents pro rata portion of the 2019 annual Deferred Share Units awards granted to the Company's directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person."}],"balance_after":655.913,"derivative":{"underlying":"Common Stock, $0.10 par value","underlying_shares":655.913},"source":{"system":"sec-edgar","filing":"0000014272-19-000204","document":"wf-form4_157445995567267.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427219000204/wf-form4_157445995567267.xml","form_type":"4"}},{"id":3361999,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:33.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001415889-19-001365","document":"form4-11222019_071120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001365/form4-11222019_071120.xml","form_type":"4"}},{"id":3361998,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:33.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":4756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4756},"source":{"system":"sec-edgar","filing":"0001415889-19-001365","document":"form4-11222019_071120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001365/form4-11222019_071120.xml","form_type":"4"}},{"id":3361997,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:33.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":970},"source":{"system":"sec-edgar","filing":"0001415889-19-001365","document":"form4-11222019_071120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001365/form4-11222019_071120.xml","form_type":"4"}},{"id":3361996,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:33.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001415889-19-001365","document":"form4-11222019_071120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001365/form4-11222019_071120.xml","form_type":"4"}},{"id":3361995,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:33.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":13266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":77.38,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":13266},"source":{"system":"sec-edgar","filing":"0001415889-19-001365","document":"form4-11222019_071120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001365/form4-11222019_071120.xml","form_type":"4"}},{"id":3361994,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:33.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":121.04,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001415889-19-001365","document":"form4-11222019_071120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001365/form4-11222019_071120.xml","form_type":"4"}},{"id":3361993,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:33.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":99.98,"expiration_date":"2026-06-15","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001415889-19-001365","document":"form4-11222019_071120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001365/form4-11222019_071120.xml","form_type":"4"}},{"id":3361992,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:33.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":112.16,"expiration_date":"2025-06-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-19-001365","document":"form4-11222019_071120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001365/form4-11222019_071120.xml","form_type":"4"}},{"id":3361991,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:33.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":115.78,"expiration_date":"2025-04-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-19-001365","document":"form4-11222019_071120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001365/form4-11222019_071120.xml","form_type":"4"}},{"id":3361990,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-22T07:30:33.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition in connection with the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 2, 2019, by and among Celgene Corporation (\"Celgene\"), Bristol-Myers Squibb Company (\"BMS\"), and Burgundy Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of BMS (\"Merger Sub\"), pursuant to which Merger Sub will merge with and into Celgene, with Celgene surviving as a direct wholly owned subsidiary of BMS and upon the effective time of such merger (the \"Effective Time\"), each share of Celgene common stock was converted into the right to receive (i) $50.00 in cash, (ii) one share of BMS common stock, and (iii) one contingent value right (\"CVR\") issued by BMS subject to and in accordance with the CVR agreement, dated November 20, 2019, by and between BMS and the Equiniti Trust Company."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-19-001365","document":"form4-11222019_071120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001365/form4-11222019_071120.xml","form_type":"4"}},{"id":3361989,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-22T07:30:33.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":2209,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition in connection with the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 2, 2019, by and among Celgene Corporation (\"Celgene\"), Bristol-Myers Squibb Company (\"BMS\"), and Burgundy Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of BMS (\"Merger Sub\"), pursuant to which Merger Sub will merge with and into Celgene, with Celgene surviving as a direct wholly owned subsidiary of BMS and upon the effective time of such merger (the \"Effective Time\"), each share of Celgene common stock was converted into the right to receive (i) $50.00 in cash, (ii) one share of BMS common stock, and (iii) one contingent value right (\"CVR\") issued by BMS subject to and in accordance with the CVR agreement, dated November 20, 2019, by and between BMS and the Equiniti Trust Company."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-19-001365","document":"form4-11222019_071120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001365/form4-11222019_071120.xml","form_type":"4"}},{"id":3419845,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-09T18:18:34.000Z","date":"2019-09-09","kind":"purchase","acquired":true,"shares":2000,"price":86.74,"value":173480.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple transactions at prices ranging from $86.50 to $86.92, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":7051,"source":{"system":"sec-edgar","filing":"0001209191-19-048863","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119048863/doc4.xml","form_type":"4"}},{"id":3471571,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2019-07-02T20:07:48.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9000,"derivative":{"exercise_price":72.01,"exercise_date":"2020-07-01","expiration_date":"2029-06-30","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001735276-19-000068","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527619000068/edgardoc.xml","form_type":"4"}},{"id":3488724,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-17T16:00:20.000Z","date":"2019-06-15","kind":"exercise","acquired":false,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":375},"source":{"system":"sec-edgar","filing":"0001415889-19-000726","document":"form4-06172019_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000726/form4-06172019_040607.xml","form_type":"4"}},{"id":3488723,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-17T16:00:20.000Z","date":"2019-06-14","kind":"exercise","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The remainder of the restricted stock units will vest as follows: 300 shares on June 14, 2020. Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."}],"balance_after":300,"derivative":{"underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001415889-19-000726","document":"form4-06172019_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000726/form4-06172019_040607.xml","form_type":"4"}},{"id":3488722,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-17T16:00:20.000Z","date":"2019-06-13","kind":"exercise","acquired":false,"shares":484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 13, 2018 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The remainder of the restricted stock units will vest in two annual installments as follows: 485 shares on June 13, 2020 and 485 shares on June 13, 2021. Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 13, 2018 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 13, 2018 vested and settled for shares of the Company's common stock."}],"balance_after":970,"derivative":{"underlying":"Common Stock","underlying_shares":484},"source":{"system":"sec-edgar","filing":"0001415889-19-000726","document":"form4-06172019_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000726/form4-06172019_040607.xml","form_type":"4"}},{"id":3488721,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T16:00:20.000Z","date":"2019-06-15","kind":"exercise","acquired":true,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The remaining one-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."}],"balance_after":2209,"source":{"system":"sec-edgar","filing":"0001415889-19-000726","document":"form4-06172019_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000726/form4-06172019_040607.xml","form_type":"4"}},{"id":3488720,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T16:00:20.000Z","date":"2019-06-14","kind":"exercise","acquired":true,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"One-third of the restricted stock units granted to the reporting person on June 14, 2017 vested and settled for shares of the Company's common stock."}],"balance_after":1834,"source":{"system":"sec-edgar","filing":"0001415889-19-000726","document":"form4-06172019_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000726/form4-06172019_040607.xml","form_type":"4"}},{"id":3488719,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T16:00:20.000Z","date":"2019-06-13","kind":"exercise","acquired":true,"shares":484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 13, 2018 vested and settled for shares of the Company's common stock."}],"balance_after":1534,"source":{"system":"sec-edgar","filing":"0001415889-19-000726","document":"form4-06172019_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000726/form4-06172019_040607.xml","form_type":"4"}},{"id":3492435,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":15604,"kind":"person","name":"BONNEY MICHAEL W","position":1,"cik":"0001219016","reported_name":"BONNEY MICHAEL W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-12T20:14:47.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date."}],"balance_after":11000,"derivative":{"exercise_price":5.6,"expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-19-036358","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219016/000120919119036358/doc4.xml","form_type":"4"}}],"next_cursor":"2019-06-12T20:14:47.000000Z,3492435"}